169 related articles for article (PubMed ID: 34365838)
1. Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction.
Yan L; Zhang Y; Wang M; Wang L; Zhang W; Ge ZR
Exp Biol Med (Maywood); 2021 Dec; 246(24):2589-2594. PubMed ID: 34365838
[TBL] [Abstract][Full Text] [Related]
2. Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease.
Santer L; López B; Ravassa S; Baer C; Riedel I; Chatterjee S; Moreno MU; González A; Querejeta R; Pinet F; Thum T; Díez J
Hypertension; 2019 Apr; 73(4):820-828. PubMed ID: 30686085
[TBL] [Abstract][Full Text] [Related]
3. lncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction.
Yan L; Zhang Y; Zhang W; Deng SQ; Ge ZR
J Cardiovasc Transl Res; 2020 Dec; 13(6):1008-1015. PubMed ID: 32440913
[TBL] [Abstract][Full Text] [Related]
4. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
[TBL] [Abstract][Full Text] [Related]
5. Serum Circulating miR-150 is a Predictor of Post-Acute Myocardial Infarction Heart Failure.
Lin X; Zhang S; Huo Z
Int Heart J; 2019 Mar; 60(2):280-286. PubMed ID: 30745540
[TBL] [Abstract][Full Text] [Related]
6. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.
Kumarswamy R; Bauters C; Volkmann I; Maury F; Fetisch J; Holzmann A; Lemesle G; de Groote P; Pinet F; Thum T
Circ Res; 2014 May; 114(10):1569-75. PubMed ID: 24663402
[TBL] [Abstract][Full Text] [Related]
7. Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction.
Li M; Wang YF; Yang XC; Xu L; Li WM; Xia K; Zhang DP; Wu RN; Gan T
Med Sci Monit; 2018 Jul; 24():5064-5070. PubMed ID: 30030914
[TBL] [Abstract][Full Text] [Related]
8. LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial.
Meessen JMTA; Bär C; di Dona FM; Staszewsky LI; Di Giulio P; Di Tano G; Costa A; Leonardy J; Novelli D; Nicolis EB; Masson S; Pinet F; Thum T; Latini R
Clin Chem; 2021 Nov; 67(12):1721-1731. PubMed ID: 34751777
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
[TBL] [Abstract][Full Text] [Related]
10. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction.
Matsumoto S; Sakata Y; Suna S; Nakatani D; Usami M; Hara M; Kitamura T; Hamasaki T; Nanto S; Kawahara Y; Komuro I
Circ Res; 2013 Jul; 113(3):322-6. PubMed ID: 23743335
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction.
Al Aseri ZA; Habib SS; Marzouk A
Vasc Health Risk Manag; 2019; 15():221-227. PubMed ID: 31410012
[No Abstract] [Full Text] [Related]
12. PRKAR1A and SDCBP Serve as Potential Predictors of Heart Failure Following Acute Myocardial Infarction.
Chen Q; Su L; Liu C; Gao F; Chen H; Yin Q; Li S
Front Immunol; 2022; 13():878876. PubMed ID: 35592331
[TBL] [Abstract][Full Text] [Related]
13. Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010.
Desta L; Jernberg T; Spaak J; Hofman-Bang C; Persson H
Eur J Heart Fail; 2016 Jan; 18(1):46-53. PubMed ID: 26503670
[TBL] [Abstract][Full Text] [Related]
14. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
[TBL] [Abstract][Full Text] [Related]
15. Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers.
Berezin AE; Berezin AA
Dis Markers; 2020; 2020():1215802. PubMed ID: 32626540
[TBL] [Abstract][Full Text] [Related]
16. Early expressed circulating long noncoding RNA CHAST is associated with cardiac contractile function in patients with acute myocardial infarction.
Wang X; Wang L; Ma Z; Liang W; Li J; Li Y; Gui Y; Ai S
Int J Cardiol; 2020 Mar; 302():15-20. PubMed ID: 31924400
[TBL] [Abstract][Full Text] [Related]
17. miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure.
Cruz MS; da Silva AMG; de Souza KSC; Luchessi AD; Silbiger VN
Heart Fail Rev; 2020 Mar; 25(2):321-329. PubMed ID: 31254148
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Serum Albumin for Developing Heart Failure Remotely after Acute Myocardial Infarction.
Yoshioka G; Tanaka A; Nishihira K; Shibata Y; Node K
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32872477
[TBL] [Abstract][Full Text] [Related]
19. Utility of pulmonary hypertension for the prediction of heart failure following acute myocardial infarction.
Mutlak D; Lessick J; Carasso S; Kapeliovich M; Dragu R; Hammerman H; Agmon Y; Aronson D
Am J Cardiol; 2012 May; 109(9):1254-9. PubMed ID: 22306210
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Troponin-I and B-Type Natriuretic Peptide Level in Acute Myocardial Infarction Patients with Heart Failure.
Islam MN; Alam MF; Debnath RC; Aditya GP; Ali MH; Hossain MA; Siddique SR
Mymensingh Med J; 2016 Apr; 25(2):226-31. PubMed ID: 27277352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]